UPDATED – Hawaii Cannabis Science Dinner & Dialogue Panel to Discuss Company’s Research on the Endocannabinoid System for Breakthrough Therapies
23 mars 2018 20h43 HE
|
CURE Pharmaceutical
LOS ANGELES, March 23, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (“CURE” or the “Company”) (OTC:CURR), an innovative drug delivery and development company, today announced that the Company will...
CURE Pharmaceutical to Participate in Hawaiian Cannabis Science Dinner & Dialogue Panel to Discuss Company’s Research on the Endocannabinoid System for Breakthrough Therapies
23 mars 2018 11h00 HE
|
CURE Pharmaceutical
LOS ANGELES, March 23, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (“CURE” or the “Company”) (OTC:CURR), an innovative drug delivery and development company, today announced that the Company will...
CURE Pharmaceutical Announces Closing of $1 Million Bridge Financing and Prepares to Uplist to NASDAQ
23 mars 2018 09h00 HE
|
CURE Pharmaceutical
OXNARD, Calif., March 23, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced that it secured a $1 million bridge financing...
Biopharmaceutical Veteran Joins CURE Pharmaceutical to Lead Manufacturing
14 mars 2018 09h00 HE
|
CURE Pharmaceutical
LOS ANGELES, March 14, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical, (OTC:CURR), an innovative drug delivery and development company, today named Steven Ruhl Vice President of Manufacturing....
CURE Pharmaceutical Adds Healthcare Luminary To Advisory Board, Secures $1 Million Investment as a Bridge to Uplisting
21 févr. 2018 06h00 HE
|
CURE Pharmaceutical
OXNARD, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced Gene Salkind, M.D. joined the company’s...
CURE Pharmaceutical Launches New Brand Focused on Patient Needs in Medication Delivery
04 janv. 2018 09h00 HE
|
CURE Pharmaceutical
OXNARD, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), an innovative drug delivery and development company, announced the launch of their new brand initiative,...
CURE Pharmaceutical to Present at 2018 Biotech Showcase
03 janv. 2018 09h00 HE
|
CURE Pharmaceutical
OXNARD, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), an innovative drug delivery and development company, will be a presenting company at the 2018 Biotech...
Cure Pharmaceutical Enters Into Product Development Agreement with Therapix Biosciences To Develop Cannabinoid-Based Product For Sleep Disorders
07 nov. 2017 09h00 HE
|
CURE Pharmaceutical; Therapix Biosciences Ltd.
OXNARD, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Cure Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology announced today that it has entered into a product...
Oak Therapeutics Announces Results of Bioequivalence Study of Company’s Oral Dissolvable Strip for Tuberculosis
03 oct. 2017 09h00 HE
|
CURE Pharmaceutical
OXNARD, Calif., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Oak Therapeutics, a subsidiary of CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company, has completed...
CURE Pharmaceutical Launches New Academic Partnership Program Providing the Company’s Proprietary CureFilm™ for More Humane and Effective Animal Research
06 sept. 2017 09h00 HE
|
CURE Pharmaceutical
OXNARD, Calif., Sept. 06, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company, today announced the launch of a new academic...